CAPD peritonitis caused by vancomycin-resistant lactobacilli.

Nephrol Dial Transplant

Department of Microbiology, St. Mary's Medical School Hospital, London.

Published: August 1990

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/5.3.235DOI Listing

Publication Analysis

Top Keywords

capd peritonitis
4
peritonitis caused
4
caused vancomycin-resistant
4
vancomycin-resistant lactobacilli
4
capd
1
caused
1
vancomycin-resistant
1
lactobacilli
1

Similar Publications

Background: Continuous ambulatory peritoneal dialysis (CAPD) is one of the kidney replacement therapy (KRT) modalities used in patients with kidney failure. It is the preferred modality in most resource-limited settings as it is more accessible and cost-effective. CAPD technique failure remains a challenge and is associated with an increased risk of morbidity and mortality.

View Article and Find Full Text PDF

Objective: To investigate the risk factors for peritonitis in peritoneal dialysis patients and to develop and validate a predictive model.

Methods: A total of 219 patients undergoing continuous ambulatory peritoneal dialysis (CAPD) who had their first peritoneal dialysis catheter placement and regular follow-up at Wuhan No. 1 Hospital between April 2020 and August 2023 were included in this study.

View Article and Find Full Text PDF

Methylobacterium populi is a fastidious, pink-pigmented, Gram-negative bacterium that has been isolated from poplar trees that are found throughout the Northern Hemisphere in both temperate and subtropical regions. Herein, we report a novel case of M. populi peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD).

View Article and Find Full Text PDF

Post-transplant hyperparathyroidism (PT-HPT) is common in kidney transplant recipients (KTRs) and can cause nephrocalcinosis and graft dysfunction. Cinacalcet is commonly used for treating PT-HPT but may induce calciuria and exacerbate nephrocalcinosis. The concurrent use of bisphosphonates with cinacalcet to prevent this complication has not been reported.

View Article and Find Full Text PDF

Background: Evidence of the effects of ketoanalogue supplements on residual kidney function (RKF) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) is limited. This study aimed to evaluate the efficacy and safety of ketoanalogues in preserving RKF in CAPD patients.

Methods: This 1-year multicenter, randomized, double-blinded, placebo-controlled trial involved 153 CAPD patients across six centers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!